Common fragile sites are specific chromosomal loci that show gaps, breaks, or rearrangements in metaphase chromosomes under conditions that interfere with DNA replication. The mechanism underlying the chromosomal instability at fragile sites was hypothesized to associate with late replication time. Here, we aimed to investigate the replication pattern of the common fragile site FRA7H, encompassing 160 kb on the long arm of human chromosome 7. Using in situ hybridization on interphase nuclei, we revealed that the replication of this region is initiated relatively early, before 30% of S phase is completed. However, a high fraction (Ïł35%) of S-phase nuclei showed allelic asynchrony, indicating that the replication of FRA7H is accomplished at different times in S phase. This allelic asynchrony is not the result of a specific replication time of each FRA7H allele. Analysis of the replication pattern of adjacent clones along FRA7H by using cell population and two-color fluorescent in situ hybridization analyses showed significant differences in the replication of adjacent clones, under normal growth condition and upon aphidicolin treatment. This pattern significantly differed from that of two nonfragile regions which showed a coordinated replication under both conditions. These results indicate that aphidicolin is enhancing an already existing difference in the replication time along the FRA7H region. Based on our replication analysis of FRA7H and on previous analysis of the common fragile site FRA3B, we suggest that delayed replication is underlying the fragility at aphidicolin-induced common fragile sites.Fragile sites are specific chromosomal loci prone to breakage, characterized by constrictions, gaps, or breaks on chromosomes from cells exposed to specific tissue culture and chemical conditions (reviewed in reference 40). They are classified as either rare or common, depending on their frequency within the population and their mode of induction. Rare fragile sites (n Ï 30 in the human genome) appear in less than 5% of the human population and segregate in specific families. Common fragile sites (n Ï 90), on the other hand, are considered to be part of the normal chromosomal structure and are thought to present in all individuals. Most of the common fragile sites (n Ï 76) are induced by aphidicolin (7), an inhibitor of DNA polymerases alpha and delta (reviewed in reference 41).Several rare fragile sites, induced by folic acid depravation, dystamycin A, or bromodeoxyuridine (BrdU) have been characterized at the molecular level (16,19,20,29,31,48). The expression of these sites is associated with expanded CGG trinucleotide or AT-rich minisatellite repeats. Three common fragile sites (FRA3B, FRA7G, and FRA7H), all induced by aphidicolin, were identified, cloned, and sequenced (15,28,46). The cytogenetic expression of each of these sites appears along a region of several hundred kilobases. No expanded repeats were found in these regions.Fragile sites were implicated in chromosomal rearrangement (8), gene amplification...